Evidence map›Paper›PMID 40766659›Full record

ArticlebioRxiv : the preprint server for biology2025

Comparative proteomic analysis of the ECM composition of the human omentum and mesentery, the main sites of ovarian cancer metastasis.

James M Considine, Clarissa Gomez, Dharma Pally, Ning Yang, Isra N Taha, Jenna Sorenson, Erin G Brooks, Pamela K Kreeger, Alexandra Naba

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

James M ConsidineDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL 60612, USA.
Clarissa GomezDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL 60612, USA.
Dharma PallyDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL 60612, USA.
Ning YangDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Isra N TahaDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL 60612, USA.
Jenna SorensonDepartment of Biomedical Engineering, University of Wisconsin-Madison, Madison, WI 53706, USA.
Erin G BrooksDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.
Pamela K KreegerDepartment of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA.ORCID 0000-0001-8193-1007
Alexandra NabaDepartment of Physiology and Biophysics, University of Illinois Chicago, Chicago, IL 60612, USA.ORCID 0000-0002-4796-5614

Funding

UW COMPREHENSIVE CANCER CENTER SUPPORTP30CA014520 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Justine Yang Bruce · 1985 to 2026
$142.6M
Engineered ECM platforms to analyze progression in high grade serous ovarian cancerR01CA232517 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI CAMPAGNOLA, PAUL J, KREEGER, PAMELA K · 2018 to 2022
$2.4M
Elevated collagen I and fibronectin in the ovarian cancer pre-metastatic nicheR01CA290693 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Pamela K Kreeger · 2025 to 2026
$1.2M
Acquisition of a Q-Exactive HF Mass SpectrometerS10OD027016 · OD · UNIVERSITY OF ILLINOIS AT CHICAGO · PI COLOGNA, STEPHANIE M · 2019 to 2019
$600k
Enhanced mass-spectrometry-based approaches for in-depth profiling of the cancer extracellular matrixR21CA261642 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI GAO, YU, NABA, ALEXANDRA · 2022 to 2024
$553k
Automated Tissue MicroarrayerS10OD023526 · OD · UNIVERSITY OF WISCONSIN-MADISON · PI MATKOWSKYJ, KRISTINA A. · 2018 to 2018
$184k
NCI NIH HHS P30 CA014520NCI NIH HHS R01 CA232517NCI NIH HHS R01 CA290693NCI NIH HHS R21 CA261642NIH HHS S10 OD023526NIH HHS S10 OD027016
6 · The paper itself

Abstract

Due to its limited symptoms, high-grade serous ovarian cancer (HGSOC) has frequently metastasized extensively throughout the peritoneal cavity prior to its diagnosis, resulting in an overall five-year survival rate of less than 50%. The greater omentum and the small bowel mesentery are two of the most common metastatic sites in advanced HGSOC. However, the mechanisms underlying HGSOC metastatic tropism remain unknown. The extracellular matrix is a complex and dynamic meshwork of proteins that provides biochemical and mechanical signals to surrounding cells and has been shown to drive the dissemination of several cancer types to preferential distant sites. Here, using histological assessment and proteomics, we examined the composition of the extracellular matrix of paired omentum and mesentery samples from disease-free adult females. We found that the fibrillar collagen content of the mesothelial layer of the omentum was significantly higher than that of the mesentery. Using ECM-focused proteomics, we further defined the ECM composition - or matrisome - of these two tissues. We found that over 90% of the proteins detected were shared between the omentum and mesentery. Our analysis also revealed small subsets of tissue-specific ECM proteins. Future work will aim to test the possible functional contributions of these ECM proteins to HGSOC metastatic tropism. To facilitate the reuse of our dataset, we have deposited the raw mass spectrometry data and accompanying metadata files to the ProteomeXchange Consortium with the dataset identifier PXD061586.

Indexed as

High-grade serous ovarian cancerMass spectrometryMatrisomeMetastatic nicheTumor microenvironment

Identifiers

PMID40766659
PMCPMC12324287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.